Picture of Gritstone bio logo

GRTSQ — Gritstone bio News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

Brief: Gritstone Presents Positive Results From Two Phase 1 Coral Studies

Oct 25 (Reuters) - Gritstone bio Inc  GRTS.O :
    * GRITSTONE PRESENTS POSITIVE RESULTS FROM TWO PHASE 1 CORAL
STUDIES, PROVIDING FURTHER PROOF-OF-CONCEPT FOR SELF-AMPLIFYING
MRNA (SAMRNA) IN INFECTIOUS DISEASES
    * GRITSTONE BIO INC - INTERIM RESULTS FROM CORAL-CEPI SHOW
GOOD
TOLERABILITY AND IMMUNOGENICITY IN ALL VACCINE-NAÏVE SUBJECTS
DOSED
    * GRITSTONE BIO INC - DATA PROVIDE FURTHER SUPPORT OF
GRITSTONE'S
SELF-AMPLIFYING MRNA (SAMRNA) AS PLATFORM FOR INFECTIOUS DISEASE
VACCINES
    * GRITSTONE BIO INC - NEW DATA FROM CORAL-BOOST STUDY
DEMONSTRATE
BROAD AND DURABLE IMMUNE RESPONSE

Source text for Eikon:  ID:nGNXc45LJD 
Further company coverage:  GRTS.O 
 ((Reuters.Briefs@thomsonreuters.com;;))

Recent news on Gritstone bio

See all news